P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine

Detalles Bibliográficos
Autores principales: Evangelista, Maurizio, Piseddu, Francesco Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715154/
https://www.ncbi.nlm.nih.gov/pubmed/28132224
http://dx.doi.org/10.1186/1129-2377-16-S1-A164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715154/
https://www.ncbi.nlm.nih.gov/pubmed/28132224
http://dx.doi.org/10.1186/1129-2377-16-S1-A164

Ejemplares similares